TLDRocket
Sign in

Aeon, a Zurich health tech startup, extended its seed funding round and acquired Aware Health’s blood diagnostics assets

Acquisition Provisional 88% confidence first seen

Aeon closed an extended seed round and acquired Aware Health’s core blood diagnostics assets, including its technology and team. The company said it will integrate the assets into its AI-driven whole-body check-ups, using the regulated diagnostics stack and blood-draw network to support its European roadmap and recurring data collection.

The deal

Aeon more than USD 14 million (about EUR 12 million) Seed · announced 14 Sep 2026

Deal terms as reported in the coverage below.

Source coverage

The daily briefing

Every AI story that matters, in your inbox by 8am.

TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the day in two minutes. Follow companies and topics for alerts, or get the briefing in Slack. Free, no spam, unsubscribe anytime.